Matías Antonio
Ávila Zaragoza
Catedrático de Universidad
Publicaciones en las que colabora con Karol Marcela Córdoba Quiñones (7)
2024
-
Exploring current and emerging therapies for porphyrias
Liver International, Vol. 44, Núm. 9, pp. 2174-2190
-
Systemic messenger RNA replacement therapy is effective in a novel clinically relevant model of acute intermittent porphyria developed in non-human primates
Gut
2023
-
Nutritional Interventions with Bacillus coagulans Improved Glucose Metabolism and Hyperinsulinemia in Mice with Acute Intermittent Porphyria
International Journal of Molecular Sciences, Vol. 24, Núm. 15
2022
-
Messenger RNA as a personalized therapy: The moment of truth for rare metabolic diseases
International Review of Cell and Molecular Biology (Elsevier Inc.), pp. 55-96
-
Recent Insights into the Pathogenesis of Acute Porphyria Attacks and Increasing Hepatic PBGD as an Etiological Treatment
Life, Vol. 12, Núm. 11
2021
-
Heme oxygenase-1 inducer hemin does not inhibit SARS-CoV-2 virus infection
Biomedicine and Pharmacotherapy, Vol. 137
-
mRNA-based therapy in a rabbit model of variegate porphyria offers new insights into the pathogenesis of acute attacks
Molecular Therapy - Nucleic Acids, Vol. 25, pp. 207-219